BioSpace News Archive

BioMidwest

Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development

Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays.

March 21, 2018
·
3 min read
Business

Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast

Neovasc Inc. announced that it will report financial results for the year ended December 31, 2017.

March 21, 2018
·
1 min read
BioMidwest

Medline Unveils New Solution to Wipe Out Pre-Op Bacteria at AORN Surgical Conference & Expo 2018

Clinicians looking for effective alternatives to decolonizing the nose before surgery will be among the first to check out the Medline’s Ready.Set.Care. kit at the 2018 AORN Surgical Conference & Expo in New Orleans, March 24-28, at booth 829.

March 21, 2018
·
2 min read
Policy

AKORN, INC. INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Akorn, Inc.

The law firm Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the publicly traded securities of Akorn, Inc. between March 1, 2017 and February 26, 2018.

March 21, 2018
·
2 min read
Biotech Beach

New Biocompatible Particle Embolic Device to Therapeutically Slow or Stop Blood Flow Presented at the 2018 Society of Interventional Radiology (SIR) Conference

A scientific presentation of a new vascular embolic device was presented today at the 2018 Society Of Interventional Radiology conference in Los Angeles, California.

March 21, 2018
·
2 min read
Job Trends

Now Entering the Mobile Era: In-Situ’s Aqua TROLL® 500

In-Situ is launching the new Aqua TROLL® 500, a cost-effective multiprobe ideal for both spot checks and long-term monitoring.

March 21, 2018
·
2 min read
Cronos Group Inc. Announces $100 Million Bought Deal

Cronos Group Inc. is pleased to announce that it has entered into an agreement with a syndicate of underwriters co-led by GMP Securities L.P. and BMO Capital Markets to sell 10,420,000 common shares at a price of $9.60 per common share, for gross proceeds of approximately $100.0 million.

March 21, 2018
·
7 min read
Biotech Beach

Neuropathy Action Foundation Announces 12th Annual “Neuropathy Action Awareness Day, “Largest Neuropathy-Related Patient Event In The United States

Registration Now Open for LA-Area Event Dedicated to Raising Awareness of Neuropathy

March 21, 2018
·
2 min read
Business

CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update

CollPlant is a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products.

March 21, 2018
·
21 min read
Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

March 21, 2018
·
4 min read